LUGPA 2025 CME Enduring Program: Operationalizing the Science -Translating New Concepts into Clinical Practice-2025 CME Program Part 8

Video Transcription

Video Summary

The video features Ronnie Abaza, a leading surgeon with extensive experience in robotic multiport prostatectomy, discussing advancements in the procedure. He highlights the use of low pneumoperitoneum pressure (around 6-7 mmHg) during surgery, supported by randomized trials showing benefits such as less postoperative pain and faster bowel function. Abaza shares his success with same-day robotic prostatectomy, sending nearly all patients home the same day without increased readmissions, emphasizing opioid avoidance through patient education and non-narcotic pain management. He details innovative techniques like the Retzius-sparing and the anterior Retzius (Hood) approach, both improving early continence rates. He also discusses the clipless technique and argues that multiport prostatectomy remains the gold standard over single-port robotic methods, especially for ambulatory surgery centers.<br /><br />The panel then shifts to prostate cancer biomarkers beyond PSA. Experts discuss the limitations of PSA and the role of new urine- and blood-based biomarkers in refining biopsy decisions, especially to avoid unnecessary procedures. They emphasize understanding each test's predictive values and integrating them with clinical factors and MRI results. The conversation includes case examples illustrating the use of biomarkers and imaging to guide biopsies. Overall, the session stresses ongoing innovation in robotic surgery and prostate cancer diagnostics to improve patient outcomes and reduce overtreatment.

Keywords

robotic multiport prostatectomy

low pneumoperitoneum pressure

same-day surgery

opioid avoidance

Retzius-sparing technique

prostate cancer biomarkers

biopsy decision refinement